Non-invasive screening test specifically developed to empower women —including those with known germline mutations or elevated risk factors—, to proactively monitor their health and detect early indicators of breast cancer before symptoms arise.
Tests Venient Sx
Last update: June 7th, 2026.
Tests specially developed as high-precision, non-invasive screening solutions designed to empower individuals —including those with known germline mutations, hereditary predispositions, or elevated risk factors—, to proactively monitor their health and detect early indicators of cancer before any physical symptoms arise. By integrating advanced analytical laboratory medicine with intelligent diagnostic algorithms, these screening panels allow for the early identification of subtle tumor biomarkers, drastically expanding the preventative window during its most manageable preclinical phases.
Engineered for proactive wellness and high-risk surveillance, these patient-initiated and clinician-guided testing options excel in providing clear, actionable biological insights that support early clinical action and lifetime longevity. This breakthrough preventive paradigm not only minimizes the physical and psychological trauma historically associated with late-stage oncological interventions but also optimizes long-term healthcare costs and institutional resources, transforming unpredictable health risks into manageable, data-driven preventative outcomes.
Breast Cancer Screening (Sx) Test
Colorectal Cancer Screening (Sx) Test
Non-invasive screening test specifically developed to empower men and women —including those with known germline mutations or elevated risk factors—, to proactively monitor their health and detect early indicators of colorectal cancer before symptoms arise.
Liver Cancer Screening (Sx) Test
Non-invasive screening test specifically developed to empower men and women —including those with known germline mutations or elevated risk factors—, to proactively monitor their health and detect early indicators of liver cancer before symptoms arise.
Lung Cancer Screening (Sx) Test
Non-invasive screening test specifically developed to empower men and women —including those with known germline mutations or elevated risk factors—, to proactively monitor their health and detect early indicators of lung cancer before symptoms arise.
Epithelial Ovarian Cancer Screening (Sx) Test
Non-invasive screening test specifically developed to empower women —including those with known germline mutations or elevated risk factors—, to proactively monitor their health and detect early indicators of ovarian cancer before symptoms arise.
Epithelial, Germ Cell and Stromal Ovarian Cancer Screening (Sx) Test
Non-invasive screening test specifically developed to empower women —including those with known germline mutations or elevated risk factors—, to proactively monitor their health and detect early indicators of ovarian cancer before symptoms arise.
Prostate Cancer Screening (Sx) Test
Non-invasive screening test specifically developed to empower men —including those with known germline mutations or elevated risk factors—, to proactively monitor their health and detect early indicators of prostate cancer before symptoms arise.
Multi-Cancer Early Detection (MCED) Screening (Sx) Test for Male
Non-invasive screening test specifically developed to empower men —including those with known germline mutations or elevated risk factors—, to proactively monitor their health and detect early indicators of several types of cancer before symptoms arise.
Multi-Cancer Early Detection (MCED) Screening (Sx) Test for Female
Non-invasive screening test specifically developed to empower women —including those with known germline mutations or elevated risk factors—, to proactively monitor their health and detect early indicators of several types of cancer before symptoms arise.
Back to Tests